Cortagen
Cortagen
Cortagen
Cortagen
Cortagen
Cortagen
Cortagen
Cortagen

Cortagen

£49.00Sold out
Out of stock
Size
ABOUT THIS COMPOUND
Description

Cortagen from Super Human Peptides UK is a highly targeted, synthetic tetrapeptide (sequence: Ala-Glu-Asp-Pro). It belongs to the advanced class of short peptide bioregulators developed by the St. Petersburg Institute of Bioregulation and Gerontology.

In laboratory research, Cortagen serves as a premier model for investigating profound neurorestoration and the reversal of age-related cognitive decline. Researchers utilize this peptide because it acts as an epigenetic switch specifically for the cerebral cortex and central nervous system. By penetrating the nucleus of neurons and interacting directly with DNA promoter regions, Cortagen stimulates the regeneration of nerve fibers and the up-regulation of vital neurotrophic factors.

Produced under GMP-compliant conditions and verified for 99% purity or higher, Cortagen is an essential tool for advanced in-vitro and in-vivo research into ischemic stroke recovery, traumatic brain injury (TBI), and neurodegenerative disease models.

WarningFor laboratory research use only. Not for human consumption.
Key Features
  • Cerebral Bioregulator: A short, 4-amino-acid peptide that acts as an epigenetic switch specifically for brain tissue.
  • Neurogenesis: Stimulates the structural repair and regeneration of damaged peripheral and central nerve fibers.
  • Ischemic Protection: Protects neurons from hypoxia (oxygen deprivation) and subsequent necrotic cell death.
  • Epigenetic Action: Directly modulates gene expression to restore youthful function to aged or damaged cortical neurons.
  • High Purity: 99% purity or higher (verified by HPLC and MS analysis).
  • Quality Standard: GMP / ISO certified manufacturing.
Research Focus
  • Ischemic Stroke Recovery: Preclinical models investigating the rapid salvage of cortical neurons and the reduction of infarct size following severe blood flow restriction.
  • Nerve Fiber Regeneration: Studying the physical regrowth and re-myelination of damaged nerve tissue in both the central and peripheral nervous systems.
  • Antioxidant Enzyme Activation: Measuring the peptide's ability to trigger the endogenous production of antioxidant enzymes (like superoxide dismutase) to combat oxidative stress in the brain.
  • Epigenetic Gene Regulation: Investigating the intracellular signaling pathways that allow the tetrapeptide to un-silence dormant DNA regions responsible for cellular repair.
  • Cognitive and Motor Restoration: Evaluating the reversal of age-related cognitive deficits and the rapid recovery of motor function following induced brain trauma.
Published Research and Study Findings

Cortagen was developed as a synthetic analogue of Cortexin, a naturally occurring polypeptide complex extracted from the cerebral cortex of young animals. Through the pioneering research of Dr. Vladimir Khavinson, scientists identified the exact four-amino-acid sequence responsible for the profound neuroprotective effects observed with Cortexin.

Laboratory studies utilizing Cortagen demonstrate a highly specific, tissue-directed mechanism. In animal models of severe ischemic stroke, Cortagen administration significantly halted the spread of neuronal death and rapidly restored normal electroencephalogram (EEG) patterns. Furthermore, in vitro studies on aged neuronal cultures showed that Cortagen induces structural remodeling, promoting the outgrowth of neurites and stabilizing the cellular cytoskeleton.

Because it repairs the root epigenetic machinery of the brain rather than acting as a temporary central nervous system stimulant, it is a cornerstone compound in modern gerontology and neurobiology.

NoteAll findings are derived from laboratory and non-clinical research settings.
Representative Scientific References
  • 1.Khavinson, V.H. et al., "Peptide bioregulators: A new class of geroprotectors," Annals of the New York Academy of Sciences, 2002.
  • 2.Chalisova, N.I. et al., "Effect of the Cortagen peptide on the regeneration of the nerve tissue," Neuroscience and Behavioral Physiology, 2006.
  • 3.Khavinson, V.H. et al., "Epigenetic regulation of gene expression by peptide bioregulators," Biogerontology, 2006.
  • 4.Mendzheritskii, A.M. et al., "Effect of cortagen on lipid peroxidation and antioxidant enzyme activity in rat brain during focal ischemia," Bulletin of Experimental Biology and Medicine, 2005.
Technical data
Specifications
Purity
≥99%, HPLC verified
Form
Lyophilised white powder
Molecular formula
C18H28N4O9
Molecular weight
444.4 g/mol
Sequence
Ala-Glu-Asp-Pro
SKU
SHP-CORTA-010
Research category
Cognitive
Storage
-20°C, protected from light
Reconstitution
Reconstitute with bacteriostatic water; swirl gently, do not shake
Research use
In-vitro laboratory research only. Not for human consumption.
Common questions
Frequently asked questions
Cortagen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Pro) developed by the St Petersburg Institute of Bioregulation and Gerontology, supplied at ≥99% purity or higher.
It is studied for nerve fibre regeneration and neurotrophic factor up-regulation in the cerebral cortex, and applied in ischaemic stroke recovery, traumatic brain injury and neurodegenerative disease models.
Cortagen is supplied at ≥99% purity, verified by HPLC with mass-spectrometry identity confirmation. Testing is carried out per batch rather than per product line, so the figures on your certificate of analysis relate to the exact lot in your vial.
Store the sealed vial at -20°C, protected from light. Once reconstituted, the solution should be kept refrigerated at 2-8°C, protected from light, and treated as a short-lived working preparation rather than a long-term stock.
Cortagen is supplied lyophilised. Reconstitute with bacteriostatic water; swirl gently, do not shake, and allow the powder to dissolve fully before use. Direct the solvent down the inside wall of the vial rather than onto the pellet, and record the volume used so working concentrations can be calculated. This applies to in-vitro laboratory work only.
All three are Khavinson-class short peptide bioregulators that act on gene expression, but each is tissue-specific. Cortagen targets the cerebral cortex, Cardiogen targets myocardial tissue, and Crystagen targets the thymus. Protocols comparing tissue selectivity across the class typically run all three.
Yes. A certificate of analysis covering HPLC purity and mass-spectrometry identity is available for every batch of Cortagen. Each vial carries a batch number on its label, and quoting that number lets us send you the certificate that matches the material you hold rather than a generic example.
Cortagen has the molecular formula C18H28N4O9 and a molecular weight of 444.4 g/mol. Those figures are stated on the certificate of analysis supplied with each batch and are the values researchers use when preparing molar calculations.
Cortagen ships from the UK to UK research addresses, with tracked dispatch and insulated packaging. It is sold for in-vitro laboratory research only: it is not a medicine, not a supplement, and not for human or veterinary consumption. Orders are accepted on the basis that the buyer is a qualified researcher.